Neovasc Inc. NVCN

Healthcare Medical Instruments & Supplies

Neovasc Inc is a specialty medical device company. It develops, manufactures and markets products for the rapidly growing cardiovascular marketplace. Its products the Neovasc Reducer (Reducer), for the treatment of refractory angina, which is not currently commercially available in the United States and has been commercially available in Europe since 2015, and the Tiara, for the transcatheter treatment of mitral valve disease, which is under clinical investigation in the United States, Canada, Israel and Europe. The company earns revenue from one source, the Reducer.

NDAQ:NVCN - Post by User

Neovasc Inc. > Volume

<< Previous

Bullboard Posts

Next >>

Comment by peterdrillingon Apr 13, 2018 11:50pm

234 Views

Post# 27884094

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Volume

Thanks Barewood. I neglected that date. Assuming that reaching the value mentioned by Nasdaq should be a challenge. Company definitely making the right moves and heading towards the right direction. Anyone who’s long here should definitely listen to the last transcript dated March 28. Company claims that each Q from now will only get better.

<< Previous

Bullboard Posts

Next >>

A potential breakthrough in spinal cord and optic nerve injury treatment